[go: up one dir, main page]

DK205083A - 4-aryl-4-piperidincarbinoler, estere, aminsalte og n-oxider deraf, deres fremstilling og anvendelse som laegemidler - Google Patents

4-aryl-4-piperidincarbinoler, estere, aminsalte og n-oxider deraf, deres fremstilling og anvendelse som laegemidler Download PDF

Info

Publication number
DK205083A
DK205083A DK205083A DK205083A DK205083A DK 205083 A DK205083 A DK 205083A DK 205083 A DK205083 A DK 205083A DK 205083 A DK205083 A DK 205083A DK 205083 A DK205083 A DK 205083A
Authority
DK
Denmark
Prior art keywords
aminal
carbinols
piperidin
oxides
aryl
Prior art date
Application number
DK205083A
Other languages
English (en)
Other versions
DK205083D0 (da
DK161699B (da
DK161699C (da
Inventor
Engelbert Ciganek
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of DK205083D0 publication Critical patent/DK205083D0/da
Publication of DK205083A publication Critical patent/DK205083A/da
Publication of DK161699B publication Critical patent/DK161699B/da
Application granted granted Critical
Publication of DK161699C publication Critical patent/DK161699C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK205083A 1982-05-07 1983-05-06 Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf DK161699C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US37622982A 1982-05-07 1982-05-07
US37622982 1982-05-07
US46804083 1983-02-25
US06/468,040 US4485109A (en) 1982-05-07 1983-02-25 4-Aryl-4-piperidinecarbinols

Publications (4)

Publication Number Publication Date
DK205083D0 DK205083D0 (da) 1983-05-06
DK205083A true DK205083A (da) 1983-11-08
DK161699B DK161699B (da) 1991-08-05
DK161699C DK161699C (da) 1992-01-13

Family

ID=27007350

Family Applications (1)

Application Number Title Priority Date Filing Date
DK205083A DK161699C (da) 1982-05-07 1983-05-06 Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf

Country Status (17)

Country Link
US (1) US4485109A (da)
EP (1) EP0094018B1 (da)
AU (1) AU560166B2 (da)
CA (1) CA1252790A (da)
DE (1) DE3375915D1 (da)
DK (1) DK161699C (da)
ES (1) ES522120A0 (da)
FI (1) FI78685C (da)
GR (1) GR77502B (da)
HU (1) HU188278B (da)
IE (1) IE55994B1 (da)
IL (1) IL68586A0 (da)
NO (1) NO162817C (da)
NZ (1) NZ204150A (da)
PH (1) PH18380A (da)
PT (1) PT76657B (da)
SU (1) SU1187718A3 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337418C (en) * 1988-03-28 1995-10-24 Engelbert Ciganek 4-aryl-4-piperiding (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof
US5019650A (en) * 1988-03-28 1991-05-28 E. I. Du Pont De Nemours And Company 4-aryl-4-piperidine (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof
US5086063A (en) * 1988-03-28 1992-02-04 Du Pont Merck Pharmaceutical Company 4-aryl-4-piperidine (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof
FR2639226B1 (fr) * 1988-11-18 1993-11-05 Sanofi Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs
EP0412798A3 (en) * 1989-08-08 1992-07-01 Merck Sharp & Dohme Ltd. Substituted pyridines, their preparation, formulations and use in dementia
USRE46117E1 (en) 1999-12-22 2016-08-23 Teva Pharmaceuticals International Gmbh Modulators of dopamine neurotransmission
US6656953B2 (en) 2000-12-06 2003-12-02 Sepracor Inc. 4,4-Disubstituted piperidines, and methods of use thereof
DE60213116T2 (de) * 2001-10-16 2007-02-08 Endo Pharmaceuticals Inc. Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung
BR0314821A (pt) * 2002-11-01 2005-08-02 Neurosearch As Derivado de piperidina, composição farmacêutica, uso do derivado de piperidina, e, método para tratamento, prevenção ou alìvio de uma doença ou um distúrbio ou uma condição de um corpo animal vivo
SE0401465D0 (sv) * 2004-06-08 2004-06-08 Carlsson A Research Ab New substituted piperdines as modulators of dopamine neurotransmission
HUE029790T2 (hu) * 2004-10-13 2017-04-28 Teva Pharmaceuticals Int Gmbh Eljárás 4-(3-metánszulfonil-fenil)-l-N-propil-piperidin elõállítására
MX2007004216A (es) * 2004-10-13 2007-10-10 Neurosearch Sweden Ab Proceso para la sintesis de 4-(3-sulfonil)-piperidinas.
WO2013086425A1 (en) 2011-12-08 2013-06-13 IVAX International GmbH The hydrobromide salt of pridopidine
US20130267552A1 (en) 2012-04-04 2013-10-10 IVAX International GmbH Pharmaceutical compositions for combination therapy

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL88063C (da) * 1950-12-05
FR1049588A (fr) * 1950-12-05 1953-12-30 Schering Corp Procédé ?? préparation de pipéridines substituées
US2832786A (en) * 1956-02-27 1958-04-29 Wm S Merrell Co Phosphoramides
AT214445B (de) * 1957-08-14 1961-04-10 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen, substituierten 1-(β-Oxyäthyl)-4-phenylpiperidinen
GB841120A (en) * 1958-02-12 1960-07-13 J F Macfarlan & Co Ltd Improvements in or relating to piperidine compounds
GB888657A (en) * 1958-07-14 1962-01-31 J F Macfarlan & Co Ltd Piperidine carbinols
US3080372A (en) * 1960-03-25 1963-03-05 Res Lab Dr C Janssen 1-aroylalkyl-4-arylpiperidine derivatives
US3108211A (en) * 1960-08-08 1963-10-22 Electro Sonic Ind Inc Activation of ferroelectric elements
GB1243991A (en) * 1968-06-10 1971-08-25 Ici Ltd Piperidine, morpholine and piperazine derivatives
US3824242A (en) * 1973-01-26 1974-07-16 Research Corp Synthesis of meperidine
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
US3998832A (en) * 1975-04-16 1976-12-21 G. D. Searle & Co. Anti-diarrheal compounds
NO773550L (no) * 1976-10-18 1978-04-19 Searle & Co Fremgangsmaate til fremstilling av 1-(3,3,3-triarylpropyl)-4-fenyl-4-piperidinmetanoletere
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
FR2408602A2 (fr) * 1977-11-15 1979-06-08 Synthelabo Nouveaux derives de piperidine et leur methode de preparation
US4228288A (en) * 1978-11-29 1980-10-14 Eli Lilly And Company Certain substituted 3,4,5,6-tetrahydropyridinium salt intermediates
US4284635A (en) * 1978-11-29 1981-08-18 Eli Lilly And Company Analgesic 1,2,4,5-tetra-alkyl-4-arylpiperidines
US4236009A (en) * 1979-06-21 1980-11-25 Eli Lilly And Company Method of preparing 4A-arylhexahydro-1H-2-pyrindines and 4A-aryloctahydroisoquinolines
US4277608A (en) * 1979-06-21 1981-07-07 Eli Lilly And Company Method of preparing 4a-arylhexahydro-1H-2-pyrindines and 4a-aryloctahydroisoquinolines

Also Published As

Publication number Publication date
DK205083D0 (da) 1983-05-06
EP0094018B1 (en) 1988-03-09
FI78685B (fi) 1989-05-31
IL68586A0 (en) 1983-09-30
NZ204150A (en) 1985-05-31
GR77502B (da) 1984-09-24
EP0094018A2 (en) 1983-11-16
EP0094018A3 (en) 1985-11-06
PT76657B (en) 1986-04-16
US4485109A (en) 1984-11-27
SU1187718A3 (ru) 1985-10-23
IE55994B1 (en) 1991-03-13
NO162817C (no) 1990-02-21
FI78685C (fi) 1989-09-11
IE831040L (en) 1983-11-07
NO831588L (no) 1983-11-08
PH18380A (en) 1985-06-19
DK161699B (da) 1991-08-05
NO162817B (no) 1989-11-13
HU188278B (en) 1986-03-28
AU1431183A (en) 1983-11-10
FI831567L (fi) 1983-11-08
DE3375915D1 (de) 1988-04-14
FI831567A0 (fi) 1983-05-06
CA1252790A (en) 1989-04-18
DK161699C (da) 1992-01-13
PT76657A (en) 1983-06-01
ES8501750A1 (es) 1984-12-01
AU560166B2 (en) 1987-04-02
ES522120A0 (es) 1984-12-01

Similar Documents

Publication Publication Date Title
DK658688A (da) 1-aryl-3-quinolin- og 1-aryl-3-isoquinolin-carboxamider, deres fremstilling og anvendelse som laegemidler
DK143588A (da) Substituerede 9-amino-tetrahydroacridiner, deres fremstilling og anvendelse som laegemidler
DK139287D0 (da) Tertiaere hydroxyalkylxanthiner, deres fremstilling og anvendelse som laegemidler
DK368480A (da) Optisk aktive 1,4-dihydropyridiner fremgangsmaader til deres fremstilling og deres anvendelse som laegemidler
DK267489D0 (da) 1-deoxy-nojirimycin-derivater, deres fremstilling og anvendelse som laegemidler
DK381985D0 (da) 3-pyridylforbindelser, deres fremstilling og anvendelse som laegemiddel
DK205083A (da) 4-aryl-4-piperidincarbinoler, estere, aminsalte og n-oxider deraf, deres fremstilling og anvendelse som laegemidler
DK298984A (da) Tetrahydropyridazinoner eller syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter og disses fremstilling
DK593883D0 (da) Substituerede phenylsulfonyloxybenzimidazolcarbaminater,fremgangsmaade til deres fremstilling og deres anvendelse som laegemiddel
DK219685A (da) Heterocycliske forbindelser, deres fremstilling og anvendelse som laegemidler
DK366888D0 (da) Castanosperminestre og -glykosider, deres fremstilling og anvendelse som laegemidler
DK581586A (da) N-(pyrrol-l-yl)-pyridinaminer, deres fremstilling og anvendelse som laegemidler
DK103987D0 (da) Substituerede 1,3,4,9-tetrahydropyranooe3,4-baaindol-l-eddikesyrer, deres fremstilling og anvendelse som laegemidler
DK144885D0 (da) Substituerede 4-hydroxybenzopyraner eller farmaceutisk acceptable additionssalte deraf, deres fremstilling og anvendelse som laegemidler
DK420986D0 (da) Dihydropyridin-2-hydroxyaminer, fremgangsmaade til deres fremstilling og deres anvendelse i laege-midler
DK284688D0 (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler
DK614186D0 (da) Substituerede piperazin-1,4-naphtalendioner, deres fremstilling og anvendelse som laegemidler
DK442183D0 (da) Thiatriazin-derivater, fremgangsmader til fremstilling deraf og deres anvendelse som laegemidler
DK527180A (da) Substituerede 2-amino-3,4-dihydropyridinderivater fremgangsmar ade til deres fremstilling og deres anvendelse som laegemidle
DK70484A (da) N-sulfenylerede hydantoiner, deres fremstilling og anvendelse som mikrobiocider
DK602184A (da) Imidazoquinoliner, deres fremstilling og anvendelse som laegemidler
DK501888A (da) 6-mercaptopurin-derivater, deres fremstilling og anvendelse som laegemidler
DK648389D0 (da) Anthracylin-derivater, deres fremstilling og anvendelse som laegemidler
DK555486D0 (da) Cephalosporiner eller salte deraf, deres fremstilling og anvendelse som laegemidler
NO822534L (no) Oxotienobenzooksepiner, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel

Legal Events

Date Code Title Description
PBP Patent lapsed